In a prospective registry prevalent and incident patients diagnosed with group 1 to 5 pulmonary hypertension will be enrolled. In an integrated biobank body fluid samples will be collected at enrollment and sequentially during treatment with targeted drugs for pulmonary hypertension.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of pulmonary hypertension group 1 to 5
Ability to give informed consent
You may not be if
\- Withdrawal of informed consent
Clareo Health | Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension
